Nygard Biotec
Nygard Biotec

The Movie

Peter Nygards 4 Step Strategy:

Step 1: Obtaining the right technology

University of Oregon Scientist, Dr. Shoukhrat Mitalipov explains, “It’s been 15 years since we invented the embryonic stem cell, and no one has been able to figure out how to use it.”   The procedure inserts adult human DNA into an unfertilised human egg, so that the growing stem cells can be used to treat serious disease and ageing.

 

“The way in which these stem cell lines were derived is from embryos that were created in the process of In Vitro Fertlisation (IVF), and, in fact, there are hundreds of thousands of these embryos that are simply being discarded,” said Dr. Francis Collins, Director of the US National Institute of health.

Step 2: Finding the perfect setting

After lengthy international travels, Mr. Nygard settled in the Bahamas for good reason many years ago.  Recognised by its popularity among A-class celebrities and the rich and famous, the Bahamas is a celebrated holiday destination with beautiful weather, a welcoming economy and an ever-friendly culture.  He believes that his new home would be perfect for both his business and the Bahamian people.

Step 3: Educating the law-makers

Mr Nygard needed the Bahamian government to willingly adopt supportive legislation for his stem cell studies.  This was a critical step in the progression of his extensive plans for research. He says that Bahama’s current Prime Minister Perry Christie "showed tremendous courage and political savviness to guide this through the legislature”.

 

PM Christie states in the video above that:“Two years ago Peter Nygård called me to say that if your country is prepared to pass legislation, I will find a way to bring scientists who I have retained. I am prepared to have them come into the Bahamas.”

 

The stem cell bill was passed in January of 2014 and was the first time the Bahamas’ ‘Medical Act’ had been revised in over 12 years. 

Step 4: Planing and construction of the scientific facilities

The construction of a multi-million dollar facility which develops both genomic sequencing and embryonic stem-cell technology would be the first of its kind anywhere in the world. 

 

While importing the most advanced stem cell technologies available, the aim is to also expand research into commercial genome sequencing (GS). This is described as the mapping of an organism’s entire DNA sequence, potentially used to predict one’s risk of developing a range of genetically inherited pathologies. 

Stem Cell News: Science Daily

HLF-gene controls generation of our long-term immune system (Wed, 22 Nov 2017)
>> Read more

Key signaling protein for muscle growth (Mon, 20 Nov 2017)
>> Read more

Brain cell advance brings fresh hope for Creutzfeldt-Jakob disease therapies (Mon, 20 Nov 2017)
>> Read more

Deletion of a stem cell factor promotes traumatic brain injury recovery in mice (Fri, 17 Nov 2017)
>> Read more

Investigating patterns of degeneration in Alzheimer's disease (Fri, 17 Nov 2017)
>> Read more

Brain astrocytes linked to Alzheimer's disease (Fri, 17 Nov 2017)
>> Read more

Paraplegic rats walk and regain feeling after stem cell treatment (Thu, 16 Nov 2017)
>> Read more

Cell-based therapy for type 1 diabetes? (Wed, 15 Nov 2017)
>> Read more

Key to unlock blocked differentiation in microRNA-deficient embryonic stem cells (Wed, 15 Nov 2017)
>> Read more

Why testicular cancer is so responsive to chemo (Tue, 14 Nov 2017)
>> Read more

Effective therapy against glioblastoma by attacking telomeres (Mon, 13 Nov 2017)
>> Read more

Innovative genetic, cellular techniques help identify multiple disease targets (Mon, 13 Nov 2017)
>> Read more

Improving the neuron factory: New modulator of stem cell identity found (Mon, 13 Nov 2017)
>> Read more

Understanding the Berlin patient's unexpected cure of HIV (Fri, 10 Nov 2017)
>> Read more

Induced pluripotent stem cells show astrocyte-neuron impact on brain pathology in autism (Thu, 09 Nov 2017)
>> Read more

Print Print | Sitemap
© Nygard Biotech